Obesity Clinical Trial
Verified date | August 2017 |
Source | Gramercy Research Group |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will test ways to improve health behaviors using an intervention that has been specially designed for African-American men. The program, called Active & Healthy Brotherhood (AHB), will provide information on basic health, and healthy eating, physical activity, stress management, and how to get medical care when needed.The AHB intervention will be compared to a control group that will receive basic health information in videos and brochures.
Status | Active, not recruiting |
Enrollment | 332 |
Est. completion date | June 30, 2018 |
Est. primary completion date | July 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 21 Years to 64 Years |
Eligibility |
Inclusion Criteria: 1. AA (based on self-report) 2. self-reported male 3. aged at least 21 years 4. non-institutionalized (i.e., community-dwelling, not living in assisted living facilities, nursing homes, etc.) 5. at high risk for developing chronic disease (e.g., not meeting current guidelines for PA and/or F&V intake; current smoker; diagnosed with high cholesterol) or 6. currently diagnosed with diabetes, hypertension, or cardiovascular disease 7. residents of Forsyth County, NC (or surrounding areas and able to attend group sessions in Forsyth County). Exclusion Criteria: 1. have had a cardiovascular procedure (e.g., heart surgery), heart attack, heart failure, stroke in the last 6 months 2. have cognitive, visual, auditory, physical functional (e.g., unable to walk unassisted), or language impairment precluding participation in group discussion, learning activities, or data collection. 3. currently achieve >150 min/wk of moderate intensity PA or >75 min/wk of vigorous intensity PA AND currently consume > 9 servings of F&V daily. 4. are currently enrolled in a chronic disease management program. 5. are unwilling to accept randomization assignment or planning to move from local area in <2 years. 6. are currently receiving chemotherapy/radiation treatments. Participants will be required to obtain approval from a health care provider prior to participation in the study if they: 1. are unable to participate in moderate PA due to physical limitations as indicated by positive (risk) responses on the PA Readiness Questionnaire (PAR-Q) and/or physician disapproval on the PAR Medical Examination. 2. have BP>180/>110 and/or HbA1C>12 and/or triglycerides >500. 3. have health conditions that could preclude changes to diet (e.g., irritable bowel syndrome, celiac disease) |
Country | Name | City | State |
---|---|---|---|
United States | Gramercy Research Group | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Gramercy Research Group | Arizona State University, Patient-Centered Outcomes Research Institute, Project Brotherhood, University of North Carolina, Chapel Hill, Vanderbilt University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change activity behavior (minutes per week in Total physical activity (PA) and light, moderate, vigorous PA). | Minutes per week in Total physical activity (PA) and light, moderate, vigorous PA | baseline, 6 months, 12 months | |
Primary | Change sedentary behavior (minutes per week of sedentary behavior). | Minutes per week of sedentary behavior | baseline, 6 months, 12 months | |
Primary | Change dietary intake (Fruit and vegetable servings, % fat, sodium and fiber intake). | Fruit and vegetable servings, % fat, sodium and fiber intake | baseline, 6 months, 12 months | |
Primary | Change stress management. | Identification of issues and strategies that affect stress management | baseline, 6 months, 12 months | |
Primary | Change help-seeking behaviors (Medication adherence and doctor/ER visits). | Medication adherence and doctor/ER visits | baseline, 6 months, 12 months | |
Secondary | Change blood pressure. | baseline, 6 months, 12 months | ||
Secondary | Change body weight. | baseline, 6 months, 12 months | ||
Secondary | Change blood glucose. | baseline, 6 months, 12 months | ||
Secondary | Change HbA1c. | baseline, 6 months, 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |